MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
From Bayer
Via Business Wire
Tickers BAYRY BAYZF
News headline image
Salubris Biotherapeutics Announces Updated Phase 1/2 Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the 2026 American Society of Clinical Oncology Annual Meeting
From Salubris Biotherapeutics, Inc.
Via Business Wire
News headline image
BW LPG Enters Into Agreement for Eight 90’cbm Panamax Newbuildings with Hyundai Heavy Industries
From BW LPG Limited
Via Business Wire
Tickers BWLP
News headline image
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
From Mirum Pharmaceuticals, Inc.
Via Business Wire
Tickers MIRM
News headline image
INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Sportradar Group AG (SRAD) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Tickers SRAD
News headline image
CVLT INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Commvault Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Tickers CVLT
News headline image
Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
From Exelixis, Inc.
Via Business Wire
Tickers EXEL
News headline image
Massive Bio Announces Next-Generation Reticulum Nexus™ Product Suite at ASCO 2026
From Massive Bio
Via Business Wire
News headline image
Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
From Summit Therapeutics
Via Business Wire
Tickers SMMT
News headline image
ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer
From Veracyte, Inc.
Via Business Wire
Tickers VCYT
News headline image
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL
From Incyte
Via Business Wire
Tickers INCY
News headline image
Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
From Tempus AI, Inc.
Via Business Wire
Tickers TEM
News headline image
Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting
From Immunome, Inc.
Via Business Wire
Tickers IMNM
News headline image
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Tune Therapeutics Presents Positive Phase 1b/2a Proof of Concept Data on TUNE-401: a First-in-Class Epigenetic Silencer for Patients with Hepatitis B at EASL 2026
From Tune Therapeutics
Via Business Wire
News headline image
FCPT Announces Agreement to Acquire up to 102 Mission Pet Health Veterinary Properties for $268 Million
From Four Corners Property Trust
Via Business Wire
Tickers FCPT
News headline image
AVAV INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that AeroVironment, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Tickers AVAV
News headline image
Shareholder Notice: Robbins LLP Informs Investors of the Lucid Group, Inc. Class Action
From Robbins LLP
Via Business Wire
Tickers LCID
News headline image
Ferrari Films Issues Formal Rebuttal to Forbes Article Mischaracterizing Section 168(k) as "Worthless" for Film Investors
From Ferrari Films
Via Business Wire
News headline image
YSS INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving York Space Systems Inc.
From Kirby McInerney LLP
Via Business Wire
Tickers YSS
News headline image
Tanner Introduces New AI Voice Chat Assistant to Reduce Call Center Hold Times
From Tanner Health
Via Business Wire
News headline image
KBRA Assigns AA+ Rating to State of Illinois, Build Illinois Bonds (Sales Tax Revenue), Junior Obligation Series A and B of June 2026; Affirms Parity Debt; Stable Outlook
From Kroll Bond Rating Agency, LLC
Via Business Wire
News headline image
Syncora Guarantee Inc. Announces the Availability of Certain Financial Information
From Syncora Guarantee Inc.
Via Business Wire
News headline image
$910 Million Student Housing Portfolio Sale Facilitated by Institutional Property Advisors
From Marcus & Millichap, Inc.
Via Business Wire
Tickers MMI
News headline image
Sable Offshore Corp. to Host Conference Call on June 1, 2026
From Sable Offshore Corp.
Via Business Wire
Tickers SOC
News headline image
SABA Announces Notification of Sources of Distributions
From Saba Capital Income & Opportunities Fund II
Via Business Wire
Tickers SABA
News headline image
BRW Announces Notification of Sources of Distributions
From Saba Capital Income & Opportunities Fund
Via Business Wire
Tickers BRW
News headline image
Kraken Set to Launch First CFTC-Regulated Perpetual Futures for US Traders
From Kraken
Via Business Wire
News headline image
Corcept Presents New Data at ASCO 2026: Lifyorli™ Overall Survival Across All Subgroups of Patients with Platinum-Resistant Ovarian Cancer, Including Those with Recent Taxane Exposure
From Corcept Therapeutics Incorporated
Via Business Wire
Tickers CORT
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story